The longitudinal course of psychopathology in
Cushing's syndrome after correction of hypercortisolism.
However, many of the symptoms associated with excessive cortisol production in patients with
Cushing's syndrome (e.
In about 15 percent of patients with
Cushing's syndrome, the cause can be traced to an abnormality of the adrenal glands, most often an adrenal tumor.
Coverage of the
Cushing's Syndrome pipeline on the basis of route of administration and molecule type.
The Phase 2 clinical trial is a two-part multicenter study consisting of a six-week open-label intra-subject dose-escalation period and a 4-week double-blind randomised withdrawal period to assess the efficacy and safety of orally-administered ATR-101 in patients with endogenous
Cushing's syndrome.
Approximately 40% of endogenous causes of
Cushing's syndrome are ACTH producing pituitary tumors and ACTH producing non-pituitary tumors such as tumors of the lung, prostate, testis, parotid or pancreas.
In conclusion, schizophrenia can be the initial presentation of
Cushing's syndrome and may improve rapidly after excess cortisol is reduced.
The radiological investigation of occult ectopic ACTH-dependent
Cushing's syndrome.
Cushing's syndrome is a constellation of signs and symptoms caused by an overproduction of cortisol, which results in a variety of abnormalities in the hypothalamic-pituitary-adrenal axis.
Utility of salivary cortisol measurements in
Cushing's syndrome and adrenal insufficiency.
Pharmaceutical company Corcept Therapeutics Incorporated (NASDAQ:CORT) unveiled on Friday the submission of its New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the use of CORLUX in
Cushing's Syndrome.
Addresses lifestyle, aging, and pregnancy; gives sample diets for heart disease, liver disease, kidney disease, urinary tract stones, pancreatitis,
Cushing's syndrome, Addison's disease, allergies, gastrointestinal disease, skin, and cancer.
